GENEVA, July 9 -- EIONCELL INC. filed a patent application (KR2025/023225) for “CD20-TARGETING BITE-SECRETING CD19-TARGETING CAR-T CELL THERAPEUTIC AGENT”. With publication no. WO/2026/147189, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 40/42
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....